Plasma ceruloplasmin in chronic renal failure patients undergoing haemodialysis

Journal of Clinical and Diagnostic Research

Volumn 4, Issue 1, 2010, Pages 2058-2060

  Ashok, K J ^a   Sajida, M P ^b   Joseph, S ^b  

^a FATHER MULLER MEDICAL COLLEGE   (India)

^b UNIVERSITY OF CALICUT   (India)

Author keywords

Ceruloplasmin; Haemodialysis; Renal failure

Indexed keywords

CERULOPLASMIN;

ARTICLE; CERULOPLASMIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HOSPITAL; HUMAN; MEDICAL EXAMINATION;

EID: 77649217163     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. th edition, by Kasper, Brunwald, Fauci, Hauser, Iongo, Jameson 1639 - 1644.
2. De Filippi C.R., Christenson R.H., B - Type Natriuretic Peptide (BNP) / NT - pro BNP and Renal Function: Is the controversy over? Clinical Chemistry 2009; 55; 1271-1273.
3. Gitlin JD, Aceruloplasminemia:Paediatr - Res. 1998; 44, 271 -276.
4. L. Rydén, Ceruloplasmin. In: R. Lontie, Editor, Copper proteins and copper enzymes, volume III, CRC Press, Boca Raton, FL 1984; 37-100
5. E.L. Saenko, A.I. Yaropolov and E.D. Harris, Biological functions of ceruloplasmin expressed through copperbinding sites and a cellular receptor. J. Trace Elem. Exp. Med. 1994; 7; 69-88.
6. T L Ortel, N Takahashi, and F W Putnam, Structural model of human ceruloplasmin based on internal triplication, hydrophilic / hydrophobic character, and secondary structure of domains. PNAS. 1984 81:4761-4765
7. Suderman FW., Nomoto S., Measurement of human ceruloplasmin by its p-Phenylenediamine Oxidase activity. Clinical Chemistry. 1970; 16; 903 - 910
8. Bustamenta J., Martin M., Dc Paula de Pedro, Manchado O. Changes in Copper and ceruloplasmin in chronic renal Insufficiency Treated by hemodialysis and peritoneal dialysis. Nephron. 1978; 22; 312 - 313.
9. Kruszewski M: Labile iron pool: The main determinant of cellular response to oxidative stress. Mutat Res.2003; 531: 81-92.
10. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S: Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002; 22: 6578 -6586.
11. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G: Ceruloplasmin: An acute phase reactant that scavenges oxygenderived free radicals. Ann N Y Acad Sci. 1982; 389 : 368 -379,
12. Gutteridge JM: Iron and oxygen radicals in brain. Ann Neurol. 1992; 32 : S16 -S21,
13. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G: Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem. 1979; 254 : 4040 -4045,
14. Park YS, Suzuki K, Mumby S, Taniguchi N, Gutteridge JM: Antioxidant binding of caeruloplasmin to myeloperoxidase: Myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact. Free Radic Res. 2000; 33: 261-265.
15. Loughrey. C.M, Young. I.S, Lightbody. J.H, McMaster. D, McNamee. P.T and Trimble. E.R Oxidative stress in haemodialysis Q J Med. 1994; 87: 679-683
16. Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS., The Ferroxidase Activity of Caeruloplasmin Is Reduced in Haemodialysis Patients Nephron. 2000 ;84;211 -217